Please use this identifier to cite or link to this item: http://hdl.handle.net/11718/22166
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMathur, Ajeet-
dc.date.accessioned2019-06-04T22:34:29Z-
dc.date.available2019-06-04T22:34:29Z-
dc.date.issued2017-12-20-
dc.identifier.urihttp://hdl.handle.net/11718/22166-
dc.description.abstractDiagnostics services in India were growing at 20% annually with billing of USD 3.4 billion. With WTO’s GATS, foreign competition was arising. Dr. Lal PathLabs had formidable brand recognition and Dr. Arvind Lal was wondering whether to accept private equity and induct management professionals to keep pace with competitors through acquisitions or greenfield or sell out. He worried over loss of proprietary control. The industry practice of incentivizing doctors for referrals meant that acquisitions brought perverse incentive systems. The choice of compromising ethics or inventing another business model had to be made alongside whether to expand in India or abroad.en_US
dc.publisherIndian Institute of Management Ahmedabaden_US
dc.relation.ispartofseriesBP0408(A);-
dc.subjectmanagementen_US
dc.subjectincentivizingen_US
dc.titleDr. Lal Pathlabs (A)en_US
dc.typeCases and Notesen_US
Appears in Collections:Cases and Notes

Files in This Item:
There are no files associated with this item.


Items in IIMA Institutional Repository are protected by copyright, with all rights reserved, unless otherwise indicated.